Print Page Site Map Home News Congenix will be presenting at BioPartnering North America 2010
 
Congenix  
company overview
services
contact us
job opportunities
news
 
Congenix will be presenting at BioPartnering North America 2010

Vladimir Novakovskiy, MD, Ph.D., Managing Director and co-founder of Congenix will be attending this year’s BioPartnering North America 2010 meeting being held in Vancouver Canada from January 24th to the 26th, 2010. Also attending for Congenix will be Steve Solomon, Director of Business Development for North America. Mr. Solomon will also be a presenter during this event.

BioPartnering North America promotes one-to-one meetings with biotech and pharma executives as well as outsourcing companies from around the world to identify and enter into strategic relationships. In addition to productive partnering, BioPartnering North America offers high level workshops, panels, company presentations and exhibits. BioPartnering North America has been held annually for 8 years in the Vancouver and is supported by many of the leading private and public industry institutions.

Congenix is a CRO conducting Phases I to IV clinical trials in Russia and Eastern Europe. We are a geographically focused expert CRO that concentrates on regulatory affairs, clinical monitoring, project management, investigational site management, study supplies custom clearance, warehousing and distribution. Together with our close partner, Health Decisions, Inc, a global clinical research organization, we are able to provide a full range of services including Data Management and Biostatistics. Health Decisions, Inc. leads the industry in trial efficiency through integrated technology and agile clinical development methods that apply adaptive principles to both trial design and operations.

Besides being a presenter, Mr. Solomon and Dr. Novakovskiy will be meeting with biotech and pharma companies interested in the hearing about the advantages of conducting clinical trials in Russia and Eastern Europe. A growing number of medical companies recognize that there are advantages to doing studies in these areas that include high recruitment rates, an excellent selection of high-quality investigational sites, and study costs savings that can reduce per patient costs as compared to Western Europe and the U.S.

Congenix is currently accepting meeting requests during this event. If interested, please feel free to contact Dr. Novakovskiy or Mr. Solomon.

Dr. Novakovskiy


Mr. Solomon

11.12.2009


Back
search
Design by
Dot Interactive